Transforming growth factor beta superfamily ligand (TGF-β superfamily ligand)

The **transforming growth factor beta superfamily ligands** are a large and diverse group of secreted, dimeric cytokines that regulate a broad range of cellular processes including cell growth, differentiation, apoptosis, immune responses, and tissue homeostasis. The superfamily encompasses multiple subgroups––including TGF-βs, bone morphogenetic proteins (BMPs), growth differentiation factors (GDFs), activins, and inhibins––all of which share a conserved “cysteine knot” structure and typically function as homo- or heterodimers. These ligands transmit signals by binding combinations of type I and type II serine/threonine kinase receptors on the cell surface, leading to the phosphorylation and nuclear translocation of SMAD transcription factors and subsequent changes in gene expression. Given their central role in controlling cellular behavior, dysregulated TGF-β superfamily signaling contributes to various diseases, notably cancer, fibrosis, and developmental and immune disorders. Numerous therapeutic agents are in development to modulate signaling of specific ligands within this superfamily for clinical benefit.

Other names

TGF-beta superfamily memberTGF-β ligandTGF-beta family ligandTGF-beta related cytokineMembers include specific examples such as "Activin," "Inhibin," "Bone morphogenetic protein," "Growth differentiation factor," among others

Ligand inhibition (e.g. neutralizing antibody or ligand trap blocks binding to receptor); Receptor blockade (blocking the downstream signaling by inhibiting ligand-receptor interaction); Modulation of Smad phosphorylation (downstream effectors of TGF-β receptor signaling); Promoting or inhibiting receptor-ligand interaction to up- or down-regulate signaling